These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38028454)

  • 1. Case Report: Hypertrophic cardiomyopathy with recurrent episodes of ventricular fibrillation and concurrent sinus arrest.
    Hamidi J; Winter J; Weber R; Dittmann S; Schulze-Bahr E
    Front Cardiovasc Med; 2023; 10():1240189. PubMed ID: 38028454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports.
    Park YM; Jang AY; Chung WJ; Han SH; Semsarian C; Choi IS
    World J Clin Cases; 2021 Dec; 9(35):11102-11107. PubMed ID: 35047624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.
    Shiozaki AA; Senra T; Arteaga E; Martinelli Filho M; Pita CG; Ávila LF; Parga Filho JR; Mady C; Kalil-Filho R; Bluemke DA; Rochitte CE
    J Cardiovasc Comput Tomogr; 2013; 7(3):173-81. PubMed ID: 23849490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel
    Li X; Tang J; Li J; Lin S; Wang T; Zhou K; Li Y; Hua Y
    Front Cardiovasc Med; 2021; 8():810291. PubMed ID: 35004917
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.
    Maurizi N; Tanini I; Olivotto I; Amendola E; Limongelli G; Losi MA; Allocca G; Perego GB; Pieragnoli P; Ricciardi G; De Filippo P; Ferrari P; Quarta G; Viani S; Rapacciuolo A; Bongiorni MG; Cecchi F
    Int J Cardiol; 2017 Mar; 231():115-119. PubMed ID: 28073660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.
    López Gil M; Arribas F; Cosío FG
    Europace; 2000 Oct; 2(4):327-32. PubMed ID: 11194600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ; Spirito P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias.
    Fujita T; Konno T; Yokawa J; Masuta E; Nagata Y; Fujino N; Funada A; Hodatsu A; Kawashiri MA; Yamagishi M; Hayashi K
    J Cardiol; 2015 Jul; 66(1):63-8. PubMed ID: 25458192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purkinje triggers of ventricular fibrillation in patients with hypertrophic cardiomyopathy.
    Hocini M; Ramirez FD; Szumowski Ł; Maury P; Cheniti G; Duchateau J; Pambrun T; Derval N; Sacher F; Cochet H; Jaïs P; Haïssaguerre M
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):2987-2994. PubMed ID: 34453363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy-A case report.
    Chin A; Healey JS; Ribas CS; Nair GM
    Indian Pacing Electrophysiol J; 2015; 15(2):121-4. PubMed ID: 26937098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome.
    Segev A; Wasserstrum Y; Arad M; Larrañaga-Moreira JM; Martinez-Veira C; Barriales-Villa R; Sabbag A
    Heart Rhythm; 2023 Oct; 20(10):1385-1392. PubMed ID: 37385464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
    Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
    J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K; Lee K; Lau CP
    J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.